Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immuron Ltd ADR (IMRN)

Immuron Ltd ADR (IMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,211
  • Shares Outstanding, K 6,946
  • Annual Sales, $ 4,720 K
  • Annual Income, $ -3,380 K
  • EBIT $ 0 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.71
  • Price/Sales 2.22
  • Price/Cash Flow N/A
  • Price/Book 1.94

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4200 +5.63%
on 12/08/25
1.7800 -15.73%
on 12/03/25
-0.1400 (-8.54%)
since 11/07/25
3-Month
1.4200 +5.63%
on 12/08/25
2.3900 -37.24%
on 10/16/25
-0.3000 (-16.67%)
since 09/09/25
52-Week
1.4200 +5.63%
on 12/08/25
2.4830 -39.59%
on 01/07/25
-0.4700 (-23.86%)
since 12/09/24

Most Recent Stories

More News
Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target

New York, New York--(Newsfile Corp. - October 17, 2025) - Emerging Growth Research today announced the initiation of coverage on Immuron Limited (Nasdaq: IMRN) with a Buy-Extended rating and a 12-month...

IMRN : 1.4996 (+2.01%)
Immuron Reports Strong Q1 FY26 Sales Growth Driven by Travelan®

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Immuron (...

IMRN : 1.4996 (+2.01%)
Immuron Expands ATM Offering to Boost Financial Resources

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Immuron (...

IMRN : 1.4996 (+2.01%)
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit...

IMRN : 1.4996 (+2.01%)
ULY : 2.67 (-5.65%)
IMUX : 0.6786 (+1.36%)
NMTC : 0.6370 (-2.75%)
SNGX : 1.6200 (+2.53%)
TMG.VN : 0.120 (+4.35%)
BLGO : 0.1775 (-0.28%)
FET : 35.86 (+4.00%)
ACFN : 16.06 (+0.94%)
NRBO : 2.36 (+0.43%)
TGCB : 0.0770 (+50.98%)
SOTK : 3.85 (-1.03%)
Immuron Limited CEO to Present at Small Cap Growth Virtual Investor Conference on December 5, 2024

Immuron Limited CEO Steven Lydeamore will present at the Small Cap Growth Virtual Investor Conference on December 5, 2024.Quiver AI SummaryImmuron Limited announced that CEO Steven Lydeamore will present...

IMRN : 1.4996 (+2.01%)
Immuron Limited Announces Participation in the LD Micro Main Event XVI

Presentation on Wednesday, October 4th at 11:00 PTMelbourne, Australia--(Newsfile Corp. - September 18, 2023) - Immuron Limited (NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical...

IMRN : 1.4996 (+2.01%)
Immuron Limited Announces Participation in the LD Micro Invitational XIII

Melbourne, Australia--(Newsfile Corp. - May 16, 2023) - Immuron Limited (ASX: IMC) (NASDAQ: IMRN) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset...

IMRN : 1.4996 (+2.01%)
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027

Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons,...

TRVN : 0.0120 (unch)
IMRN : 1.4996 (+2.01%)
IMC.AX : 0.060 (-7.69%)
LLY : 996.22 (-0.14%)
ACOR : 0.6610 (-24.86%)
SILO : 0.4422 (-2.68%)
Global Alzheimer's Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027

/PRNewswire/ -- Alzheimer's disease (AD) is a progressive and neurodegenerative disorder that attacks the brain's nerve cells or neurons, which results in loss...

TRVN : 0.0120 (unch)
IMRN : 1.4996 (+2.01%)
LLY : 996.22 (-0.14%)
ACOR : 0.6610 (-24.86%)
SILO : 0.4422 (-2.68%)
Immuron US DoD Naval Medical Research Center Receives feedback on IND Application for New Campylobacter ETEC Therapeutic

MELBOURNE, Australia, July 26, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on...

IMRN : 1.4996 (+2.01%)
IMC.AX : 0.060 (-7.69%)

Business Summary

Immuron Limited is a bio pharmaceutical Microbiome company. It focused on oral immunotherapy using polyclonal antibody products for humans. The company is involved in developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis. Immuron Limited is based in Armadale,...

See More

Key Turning Points

3rd Resistance Point 1.6367
2nd Resistance Point 1.5833
1st Resistance Point 1.5267
Last Price 1.4996
1st Support Level 1.4167
2nd Support Level 1.3633
3rd Support Level 1.3067

See More

52-Week High 2.4830
Fibonacci 61.8% 2.0769
Fibonacci 50% 1.9515
Fibonacci 38.2% 1.8261
Last Price 1.4996
52-Week Low 1.4200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar